Santhera Pharmaceuticals Holding AG (Over The Counter Market:SPHDF.PK)
| 6.80 Delayed Data As of Apr 03 |  0.00 / 0.00%Today’s Change | 6.80 Today|||52-Week Range 12.00 | -- Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 4.5M | 19.3M | 23.3M | 32.3M | |
| Cost of Goods Sold | 372.8K | 856.7K | 1.1M | 1.7M | ||
| Depreciation And Amortization | 1.2M | 3.3M | 3.4M | 3.8M | ||
| Operating Expenses | Gross Income | 2.9M | 15.1M | 18.8M | 26.8M | |
| General Expenses | 28.0M | 49.0M | 70.3M | 79.5M | ||
| Other Operating Expenses | -983.5K | 0.00 | 0.00 | -- | ||
| Research And Development | 10.9M | 17.9M | 27.0M | 39.1M | ||
| Total Operating Expenses | 28.5M | 53.2M | 74.8M | 85.0M | ||
| Non-Operating Expenses | Operating Income | -24.0M | -33.9M | -51.5M | -52.7M | |
| Extraordinary Credit | 27.2M | 0.00 | 2.6M | 2.3M | ||
| Interest Expense On Debt | -- | -- | 3.9M | 4.6M | ||
| Other Expenses | -71.7K | 184.7K | 422.7K | -221.7K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 3.0M | -33.7M | -52.1M | -55.0M | |
| Income Taxes | -3.1M | -2.3M | -261.1K | -329.0K | ||
| Net Income | 6.2M | -35.9M | -52.4M | -55.4M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 5.3M | 6.3M | 6.3M | 6.9M | |
| Shares To Calculate EPS Diluted | 5.5M | 6.3M | 6.3M | 6.9M | ||
| Earnings Per Share | EPS | $1.15 | -$5.74 | -$8.35 | -$8.03 | |
| EPS Diluted | $1.12 | -$5.74 | -$8.35 | -$8.03 | ||
